Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-026442

Options or other derivatives

  • Chief Operating Officer acquired 117,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
BILINSKY IGOR Chief Operating Officer 2026-03-09 Grant or award · Restricted Stock Units +117,500 117,500 D: show line 1 in the form
Loading xslF345X05/tm268453-1_4seq1.xml…